Mapping cerebellar degeneration in HIV/AIDS

NeuroReport

Volumn 19, Issue 17, 2008, Pages 1655-1659

  Klunder, Andrea D ^a   Chiang, Ming Chang ^a   Dutton, Rebecca A ^a   Lee, Sharon E ^a   Toga, Arthur W ^a   Lopez, Oscar L ^b   Aizenstein, Howard J ^c   Becker, James T ^b,c   Thompson, Paul M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Cerebellum; Computational anatomy; Depression; HIV; Morphometry; MRI; Neurodegeneration; Virus

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL ABUSE; ARTICLE; BRAIN MAPPING; CD4 LYMPHOCYTE COUNT; CEREBELLUM ATROPHY; CEREBELLUM DEGENERATION; CEREBELLUM VERMIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DEPRESSION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; THREE DIMENSIONAL IMAGING; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS DEMENTIA COMPLEX; ATROPHY; BRAIN; DEPRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; SPINOCEREBELLAR DEGENERATIONS; SUBSTANCE-RELATED DISORDERS; VIRAL LOAD;

EID: 56749153593     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328311d374     Document Type: Article

References (35)

1. UNAIDS (2004). 2004 Report on the global AIDS epidemic, Available at: http://www.unaids.org/wad2004/report_pdf.html
2. Levy RM, Pons VG, Rosenblum ML. Central nervous system mass lesions in the acquired immune deficiency syndrome (AIDS). J Neurosurg 1984; 61:9-16.
3. Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, et al. Multicenter AIDS Cohort Study. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 2007; 69:2213-2220. Epub 3 October 2007.
4. Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, et al. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol 2004; 61:369-376.
5. Oster S, Christoffersen P, Gundersen HJ, Nielsen JO, Pedersen C, Pakkenberg B. Six billion neurons lost in AIDS: a stereological study of the neocortex. Acta Pathol Microbiol Immunol Scand 1995; 103:525-529.
6. Chiang MC, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, et al. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-Based morphometry. Neuroimage 2006; 34:44-60.
7. Leporé N, Brun CA, Chou YY, Chiang MC, Dutton RA, Hayashi KM, et al. Generalized tensor-based morphometry of HIV/AIDS using multivariate statistics on deformation tensors. IEEE Trans Med Imaging 2008; 27:129-141.
8. Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT. Thinning of the cerebral cortex in HIV/AIDS reflects CD4 + T-lymphocyte decline. Proc Natl Acad Sci U S A 2005; 102:15647- 15652.
9. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Grant I, & the HNRC Group. Ann Neurol 1997; 42:963-972.
10. Schmahmann JD, Caplan D. Cognition, emotion and the cerebellum. Brain 2006; 129:290-292.
11. Abe H, Mehraein P, Weis S. Degeneration of the cerebellar dentate nucleus and the inferior olivary nuclei in the HIV-1-infected brains: a morphometric analysis. Acta Neuropathol 1996; 92:150-155.
12. Lopez OL, Becker JT, Dew MA, Banks G, Dorst SK, McNeil M. Speech motor control disorder after HIV infection. Neurology 1994; 44:2187-2189.
13. Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 2004; 18 (Suppl 1):S11-S18.
14. Spitzer RL, Williams JB, Gibbon M et al. Instruction manual for the Structured Clinical Interview for DSM-III-R. New York: Biometrics Research, New York State Psychiatric Institute; 1989.
15. Derogatis L. The Brief Symptom Inventory (BSI): administration, scoring and procedures manual. Baltimore: Clinical Psychometric Research; 1992.
16. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314.
17. Heaton RK. Wisconsin Card Sorting Manual. Odessa: Psychological Assessment Resources; 1981.
18. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9:179-186.
19. Spreen O, Strauss E. A Compendium of Neuropsychological Tests. New York: Oxford University Press; 1998.
20. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation; 1981.
21. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-1799.
22. Storey JD. A direct approach to false discovery rates. J R Stat Soc B 2002; 64 (Pt 3):479-498.
23. Thompson PM, Moussai J, Khan AA, Zohoori S, Goldkorn A, Mega MS, et al. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex 1998; 8:492-509.
24. Puertas I, Jiménez-Jiménez FJ, Gómez-Escalonilla C, Sayed Y, Cabrera-Valdivia F, Rojas R, Sanz-Moreno J. Progressive cerebellar syndrome as the first manifestation of HIV infection. Eur Neurol 2003; 50:120-121.
25. Paul R, Cohen R, Navia B, Tashima K. Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev 2002; 26:353-359.
26. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa RM, Grafe MR, et al. Neocortical damage during HIV infection. Ann Neurol 1991; 29:651-657.
27. Sardar AM, Hutson PH, Reynolds GP. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport 1999; 10:3513-3515.
28. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120:protection by memantine. Ann Neurol 2000; 47:186-194.
29. Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, et al. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001; 124: 1033-1042.
30. Tagliati M, Simpson D, Morgello S, Clifford D, Schwartz RL, Berger JR. Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology 1998; 50:244-251.
31. Kwakwa HA, Ghobrial MW. Primary cerebellar degeneration and HIV. Arch Intern Med 2001; 161:1555-1556.
32. Apostolova LG, Akopyan GG, Partiali N, Steiner CA, Dutton RA, Hayashi KM, et al. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord 2007; 24:91-97.
33. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004; 18 (Suppl 1):S75-S78.
34. McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005; 4:543-555.
35. Cysique LA, Maruff P, Brew BJ. Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 2004; 61: 1699-1704.